Filing Details
IRADIMED CORP (NASDAQ:IRMD) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event.
8k filedNASDAQ:IRMD
IRADIMED CORP (IRMD) Reports Material Event to SEC
Filing Details IRADIMED CORP (NASDAQ:IRMD) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event. Market Context IRADIMED…
Market Context
IRADIMED CORP's stock currently trades at $94.66 with a market capitalization of $1.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for IRADIMED CORP's stock.
All SEC filings for IRADIMED CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IRMD Stock Page
Frequently Asked Questions
Where can I read IRMD's SEC filings?
Browse all filings on our IRMD SEC filings page.
What types of SEC filings does IRADIMED CORP file?
Public companies like IRADIMED CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.